2024-12-13 04:54:31
The computer equipment sector rose short-term, Shensi Electronics rose daily, and Zhiwei Intelligent, Tonghui Information, Dahua Intelligent, Rotating Pole Information and Zhaori Technology followed suit.The humanoid robot sector rose by the daily limit of Astor and Fenda Technology, while the humanoid robot sector rose, Sanfeng Intelligent, Eft and Shenhao Technology rose by more than 10%, Astor and Fenda Technology rose by the daily limit, and Xinshida, Robot, Yijiahe, Xinjie Electric and Jingyi Intelligent followed suit.Chengyitong: The layout of the company's brain-computer interface business is mainly divided into non-invasive and invasive. Chengyitong (300430) responded to an investor's question on the interactive platform on December 10, saying that the company is also very concerned about Musk's experimental progress and technological breakthrough in brain-computer interface. The company's brain-computer interface business direction layout is mainly divided into non-invasive and invasive. In the non-invasive aspect, the company is mainly committed to integrating brain-computer interface technology with Long Zhijie's existing rehabilitation products to realize the functional upgrade of existing rehabilitation products; In the invasive aspect, the project of "Brain-computer Interface Implantable Biological Laboratory" jointly established by Naolian Technology and Daxing Medical Base Management Committee is being actively promoted. At present, the above business has not generated any income. If progress is made, the company will disclose it in strict accordance with the requirements of laws and regulations.
The two departments issued a document: improve the working mechanism of centralized procurement and implementation of medicines. Recently, the National Medical Insurance Bureau and the National Health and Health Commission issued the Notice on Improving the Working Mechanism of Centralized Procurement and Implementation of Medicines. On the basis of the original policy, the Notice further improves the centralized procurement and implementation mechanism of medicines, guides medical institutions and pharmaceutical enterprises to follow and support the centralized procurement mechanism, and consolidates and deepens the reform results of centralized procurement of medicines and medical consumables, so that more patients can benefit. The "Notice" focuses on the detailed measures from the aspects of admission, use, monitoring, assessment and feedback of centralized drug consumables, which reflects the policy orientation of coordinated supervision between departments and preferential use of selected products. (CCTV News)Yunnan Copper Industry: The shipping sales of slag tailings in Southeast Copper Industry reached a record high. According to Yunnan Copper Industry, this year, under the situation that the cement industry continued to decline, Southeast Copper Industry withstood the pressure and took the initiative to attack. By the end of November, 2024, the company had shipped 668,400 tons of slag separation tailings through the port of Ningde, and it is estimated that the annual shipping volume will reach 760,000 tons, up 40% from 2023, a record high.After 40 minutes of opening, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion, exceeding 310 billion compared with yesterday.
Pre-cooked food concept stocks moved higher, and Haixin Food, Tongqinglou, Qianweiyang Kitchen, Shuangta Food and Huifa Food had daily limit.The United States ITC issued a final ruling on 337 parts of products containing telpotide. According to China Trade Relief Information Network, on December 9, the United States International Trade Commission (ITC) announced that, For certain products containing tilloptide and products sourcing to contain tilloptide, The investigation code: 337-TA-1377) made a final ruling in part 337: to solicit opinions on the public interests involved in the suggested relief measures made by the administrative judge in this case on December 6, 2024. If there is infringement in this case, the suggested relief measures are (1) to issue a general exclusion order on the products involved in the US export, import and sale of infringing US registered patent numbers. (2) Or to the defendant Mew Mews Company Limited in Hong Kong, China, Audrey Beauty Co in Hong Kong, China, Spanish Super Human Store, American Triggered Supplies LLC (D/B/A The Triggered Brand), Strate Labs LLC of the United States and Xiamen Austria Trading Co., Ltd. (D/B/A Austria Propide) of China issued general or limited exclusion orders for infringing products exported, imported and sold in the United States. (3) Issue general or limited exclusion orders and prohibition orders to listed defendants: American Arctic Peptides LLC, American Triggered Supplements LLC (D/B/A The Triggered Brand) and American Strate Labs LLC.
Strategy guide
12-13
Strategy guide
12-13